首页 正文

Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

{{output}}
Lung cancer is the leading cause of cancer mortality. As a heterogeneous disease, it has different subtypes and various treatment modalities. In addition to conventional surgery, radiotherapy and chemotherapy, targeted therapy and immunotherapy have also been ... ...